https://egcginhibitor.com/tgf-....%ce%b2smad2-signalli
Six patients developed VAP in the framework of systemic immunosuppression demonstrated by a decrease in monocyte HLA-DR expression, lymphopenia, increased percentages of circulating T regulatory cells, and enhanced proportions of immature and immunosuppressive neutrophil subsets. During VAP, there is de novo recruitment of leukocytes in to the cerebrospinal substance, preferentially neutrophils, which exacerbated intracranial irritation. Nonpharmac
Like
Comment
Share
